Projects
Disease Burden and Surveillance
| Sr.No |
Title of the Project |
Funding Agency/Sponsor |
Collaborator/Association, if Any |
Principal Investigator |
Study Duration |
| 1. | Establish serial sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in the general population, India |
NIHR-RESPIRE unit, University of Edinburgh |
Translational Health Science and Technology Institute (Govt. of India) ,Xcyton Diagnostics Pvt Ltd |
Dr. Sanjay Juvekar |
Jan-2021-Ongoing |
| 2. | Establishing sentinel sero-surveillance to monitor the trend of SARS-nCoV-2 infection transmission in the general population in rural Western India |
Grand Challenges India- Biotechnology Industry Research Assistance Council (BIRAC) |
- |
Dr. Sanjay Juvekar |
Jan-2021-Ongoing |
| 3. | Evaluation of Immunological Parameters in Healthy Indian Adults |
Yakult Honsha Co.Ltd |
Yakult Honsha Co.Ltd |
Dr. Sanjay Juvekar |
Jul 2019-Dec 2019 |
| 4. | Etiology of Childhood Pneumonia in India: an ICMR Task Force Study |
Indian Council for Medical Research (ICMR) |
ICMR- National Institute of Epidemiology, Chennai ICMR- National Institute of Virology, Pune |
Dr. Ashish Bavdekar |
Mar 2018-Mar 2020 |
| 5. | NCD Risk Factor Surveillance II |
KEMHRC (Departmental Project) |
- |
Uddhavi Chavan |
Jan 2017-Jun 2017 |
| 6. | Nasopharyngeal pneumococcal carriage study in South Asian infants |
The University of Edinburgh/Sanofi Pasteur |
Child Health Research Foundation, Dhaka, Bangladesh |
Dr. Ashish Bavdekar, Dr. Sanjay Juvekar |
May 2017-Jan 2019 |
| 7. | National surveillance system for enteric fever in India |
Bill and Milinda Gates Foundation |
Christian Medcial College, Vellore |
Dr. Ashish Bavdekar |
Oct 2017-Mar 2019 |
| 8. | Rapid Situational analysis of Nutritional status of Tribal Children under 5 years of age in Tribal dominant blocks of Palghar District to help develop evidence-based integrated (multiple sectorial) community actions to overcome malnutrition in this tribal population. |
Departmental Study (on request from the ADHS, Govt of Maharashtra) |
Public Health System, Govt. of Maharashtra |
Dr. Sanjay Juvekar |
Nov 2016-Dec 2016 |
| 9. | Disease burden of hospitalised dengue in Vadu area in Western India |
ICMR-National Institute of Virology, Pune |
ICMR-National Institute of Virology, Pune |
Dr. Sanjay Juvekar |
Jan 2014-Mar 2015 |
| 10. | Study of Phenotypic characterization (Using HRCT) of smoking and non-smoking COPD in a rural setting in India. |
Imperial College London |
Chest Research Foundation, Pune and Imperial College London |
Dr. Sanjay Juvekar, Dr. Dayanand Shetty |
Aug 2013-May 2014 |
| 11. | Pnumonia Etiology Study |
Foundation Muriex |
- |
Dr. Ashish Bavdekar |
Jun 2012-Jun 2013 |
| 12. | Developing capacity for Tuberculosis Surveillance in Health and Demographic Surveillance Systems |
KEMHRC (Departmental Project) |
nbsp;nbsp;nbsp;nbsp;- |
Dr. Sanjay Juvekar |
Jan 2010- Jan 2011 |
| 13. | Influenza disease burden in rural communities in India |
Centre for Disease Control Atlanta |
Indian Council for Medical Research |
Dr. Sanjay Juvekar |
Sep 2010-Aug 2013 |
| 14. | Ayurgenomics Integration of Ayurveda with Genomics: a novel approach in systems biology for predictive medicine |
Council for Scientific and Industrial Research India |
CSIR-Institute of Genomics and Integrative Biology |
Dr. Sanjay Juvekar |
Apr 2009-Oct 2010 |
| 15. | Gut microflora in Children -A Pilot Study |
KEMHRC (Departmental Project) |
National Centre for Cell Sciences |
Dr. Ashish Bavdekar |
Apr 2009-Oct 2010 |
| 16. | IMVAC 2 |
Imperial College London |
- |
Dr. Ashish Bavdekar |
Jan 2008-Jan 2010 |
| 17. | Study of prevalence of copd and phenotypic characterization of smoking and non- smoking copd in a rurual setting in India (IMVAC) |
Imperial College London |
Chest Research Foundation, Pune and Imperial College London |
Dr. Siddhivinayak Hirve, Dr. Sanjay Juvekar |
Mar 2008-Jul 2009 |
| 18. | Women, WASH and Health in Rural Pune District: Identifying stress and unmet needs. |
London School of Hygiene and tropical Medicine. |
Swiss Tropical and Public Health Institue, Basel, Swizerland |
Dr. Sanjay Juvekar |
Mar 2008-Jul 2010 |
| 19. | Pune Microbiome Study |
Department of Biotechnology (Govt. of India) |
National Centre for Cell Sciences |
Dr. Sanjay Juvekar |
Aug 2006-Jan 2010 |
| 20. | Study on global ageing (SAGE) |
World Health Organization |
INDEPTH NETWORK, Accra, Ghana |
Dr. Siddhivinayak Hirve |
Jun 2005-Jun 2007 |
| 21. | Health Equity |
INDEPTH NETWORK, Accra, Ghana |
INDEPTH NETWORK, Accra, Ghana |
Dr. Sanjay Juvekar |
Jun 2005-Jun 2006 |
| 22. | Handwashing Compliance and Risk of Acute Respiratory infections |
London School of Hygine and tropical Medicine, UK |
The Hygiene Centre, London School of Hygiene & Tropical Medcine |
Dr. Siddhivinayak Hirve |
Jun 2004-Jun 2005 |
| 23. | Non-Communicable Diseases Risk Factor Survillence in INDEPTH-Network Asia/Oceania sites |
INDEPTH NETWORK, Accra, Ghana |
INDEPTH sites from Bangladesh, Indonesia, Vietnam and Thailand |
Dr. Sanjay Juvekar |
Feb 2004 - Jun 2005 |
| 24. | Vadu Health and Demographic Surveillance System |
KEMHRC (Departmental Project) |
- |
Dr. Sanjay Juvekar |
2002 - Ongoing |
Vaccine Trials
| Sr.No |
Title of the Project |
Funding Agency/Sponsor |
Collaborator/Association, if Any |
Principal Investigator |
Study Duration |
| 1. | A phase 2/3, observer-blind, randomized, controlled study to determine the safety and immunogenicity of COVOVAX [SARS-CoV-2 recombinant spike protein nanoparticle vaccine (SARS-CoV-2 rS) with Matrix-M1™ adjuvant] in Indian adults aged ≥18 years and children aged 2 to 17 years |
Serum Institute Of India Private Limited (SIIPL),ICMR, New Delhi |
- |
Dr. Ashish Bavdekar |
Sep 2021- Ongoing |
| 2. | Study on Long-term Immunogenicity of COVID-19 vaccines in vaccine-naïve seronegative and seropositive participants |
Hindustan Unilever Limited and Unilever Industries Private Limited/ Pune Knowledge Cluster |
National Chemical Laboratory and IISER Pune |
Dr. Anand Kawade |
Sep 2021- Ongoing |
| 3. | "Phase III, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0-2 Months old Low Birth Weight Infants in India" |
ICMR, New Delhi |
- |
Dr. Ashish Bavdekar |
Aug 2021- Ongoing |
| 4. | A Phase III, randomized, double-blind, placebo controlled multi-country study to demonstrate efficacy of a single dose of unadjuvanted RSV Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated LRTI in their infants up to 6 months of age |
GlaxoSmithKline Biologicals SA |
- |
Dr. Ashish Bavdekar |
Jul 2021- Ongoing |
| 5. | “A Phase II/III, Multicentre, Randomized, Open-Label, Active-Controlled Study to Assess the Immunogenicity and Safety of DTaP-IPV+Hib Vaccine Manufactured by Serum Institute of India Pvt. Ltd. in Comparison with Pentaxim® in Indian Toddlers and Infants” |
Serum Institute Of India Private Limited (SIIPL) |
- |
Dr.Anand Kawade |
Jul 2021-Ongoing |
| 6. | A phase 2/3, observer-blind, randomized, controlled study to determine the safety and immunogenicity of COVOVAX [SARS-CoV-2 recombinant spike protein nanoparticle vaccine (SARS-CoV-2 rS) with Matrix-M1™ adjuvant] in Indian adults |
Serum Institute Of India Private Limited (SIIPL),ICMR, New Delhi |
- |
Dr. Ashish Bavdekar |
Jun 2021-Ongoing |
| 7. | Randomized, double-blind, placebo-controlled, parallel-group, multi-centre phase II/III adaptive clinical trial to assess the safety and immunogenicity of Gam-COVID-Vac combined vector vaccine for SARS-СoV-2 infection in Indian Healthy Subjects |
Dr.Reddy’s Laboratory Limited |
Humen LLC |
Dr.Anand Kawade |
Jan 2021-Jul-2021 |
| 8. | Phase III, randomized, open-label, multicentre study evaluating the immunogenicity and safety of Shan6 vaccine administered. Concomitantly with or without Measles-Mumps-Rubella (MMR vaccine), to healthy toddlers in India |
Shantha Biotchincs Pvt Ltd |
- |
Dr. Anand Kawade |
Aug 2020-Feb 2021 |
| 9. | A phase II/III, observer-blind,randomized, active controlled study to determine the safety and immunogenecity of COVISHIELD(COVID-19 Vaccine)in healthy Indian adults |
Serum Institute Of India Private Limited (SIIPL) Indian Council Of Medical Research (ICMR) |
National Institute of Virolog ,Pune |
Dr. Ashish Bavdekar |
Aug 2020-Ongoing |
| 10. | A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine (NmCV-5) and to Compare its Safety and Immunogenicity with that of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age |
Serum Institute Of India Private Limited (SIIPL) |
- |
Dr. Anand Kawade |
Jan 2020-Ongoing |
| 11. | Immune Lot-to-Lot Consistency and Non-Inferiority of SHAN6™ Vaccine in Comparison to SHAN 5® + SHANIPV™ When Administered as Three Doses at 6-8, 10-12 and 14-16 Weeks of Age in Healthy Indian Infants, Concomitantly with Oral Rotavirus Vaccine |
Shantha Biotchincs Pvt Ltd |
- |
Dr. Anand Kawade |
Feb 2019-Nov 2019 |
| 12. | Immunogenicity and Safety of Rotavac® and Rotasiil® Administered in an Interchangeable Dosing Schedule among Healthy Indian Infants: A Multicentric, Phase IV, Open Labeled, Randomized, Controlled Trial |
ICMR- National Institute of Cholera & Enteric Disease (NICED), Kolkata |
National Insititue of Epidemiology (NIE), Chennai |
Dr. Ashish Bavdekar |
Mar 2019-Mar 2020 |
| 13. | “A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, Immunogenicity and Non-Interference with Concomitant Vaccinations of Serum Institute of India’s 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) in Healthy Indian Infants” |
Serum Institute Of India Private Limited |
- |
Dr. Ashish Bavdekar |
Apr 2019-Oct 2019 |
| 14. | “A Phase 3, Randomized, Double-blind study to evaluate the immunogenicity, Safety and Tolerability of Serum Institute of India’s 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) in Healthy Indian Infants.” |
Serum Institute Of India Private Limited |
- |
Dr. Ashish Bavdekar |
Nov 2019-Nov 2020 |
| 15. | An open label, randomized, active controlled, multi-centric Phase II/III, study in Indian toddlers and infants to assess the immunogenicity and safety of SIIPL HEXASIIL™ (DTwP-HepB-IPV-Hib) Vaccine in comparison with SIIPL PENTAVAC (DTwP-HepB-Hib) + Poliovac (IPV) administered as separate injections. |
Serum Institute Of India Private Limited |
- |
Dr. Anand Kawade |
Dec 2019- Jan 2020 |
| 16. | An open label, randomized, active-controlled, multi-centric phase-ii/iii study in indian toddlers and infants to assess the immunogenicity and safety of siipl hexasiiltm (dtwp-hepb-ipv-hib) vaccine in comparison with siipl pentavac (dtwp-hepb-hib) + poliovac (ipv) vaccines, administered as separate injections. |
Serum Institute Of India Private Limited (SIIPL) |
- |
Dr. Anand Kawade |
Dec 2019-Ongoing |
| 17. | A Multicenter Phase II/III Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of VPM1002 in the Prevention of Tuberculosis (TB) Recurrence in Pulmonary TB Patients after Successful TB Treatment |
Serum Institute Of India Private Limited (SIIPL) |
- |
Dr. Pradeep D'Costa |
Jun 2018-Ongoing |
| 18. | A Phase-II/III, Partially Double-blind, Randomized, Active-controlled, Multicentric Study to Assess the Immunogenicity and Safety of SIIPL’s qHPV Vaccine Administered Intramuscularly in Healthy Volunteers According to a Two-dose Schedule to Cohort 1 (Girls and Boys Aged 9-14 years) and a Three-dose Schedule to Cohort 2 (Women and Men Aged 15-26 years) as Compared to Merck’s HPV6/11/16/18 vaccine (Gardasil®). |
Serum Institute Of India Private Limited (SIIPL) |
- |
Dr. Anand Kawade |
Sep 2018-Ongoing |
| 19. | A Phase II/III, Multicenter, Randomized, Open Lable, Active Controlled, Clinical Study to Assess the Immunogenicity and Safety of Tetanus Toxoid, Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine Manufactured by Serum Institute of India Pvt. Ltd (SIIPL) in comparison with Boostrix® Vaccine of GSK in Healthy Adults, Adolescents and Children in India. - Tdap |
Serum Institute Of India Private Limited (SIIPL) |
- |
Dr. Anand Kawade |
Oct 2018- Jun 2020 |
| 20. | A phase ii/iii, multicenter, open-label, randomized study of liquid bovine rotavirus pentavalent vaccine (lbrv-pv) to evaluate lot-to-lot consistency and to compare non-inferiority with rotasiil (lyophilized brv-pv) in healthy infants in india |
PATH & Serum Institute Of India Private Limited |
- |
Dr. Anand Kawade |
Oct 2017- Oct 2018 |
| 21. | Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional dose IPV in routine immunization in post tOPV-bOPV period. |
WHO & Panacea Biotech |
- |
Dr. Ashish Bavdekar |
Jul 2017-Dec 2017 |
| 22. | "A Phase III, Multicenter, Open Label, randomized study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to evaluate lot-to-lot consistency and to Investigate potential interference with routine UIP vaccinations in healthy infants in India". |
PATH & Serum Institute Of India Private Limited |
- |
Dr. Anand Kawade |
Jan 2016-Apr 2017 |
| 23. | Nasopharyngeal pneumococcal carriage and immunogenicity with reduced and alternate dose schedule of pneumococcal conjugate vaccine in infancy. |
Bill and Milinda Gates Foundation/ INCLEN |
UCL Institute of Child Health (UCL ICH) University College London, UK Soroka University Medical Center, Israel Christian Medical College, Vellore Child Health Research Foundation, Dhaka, Bangladesh |
Dr. Ashish Bavdekar |
Jul 2016-Feb 2020 |
| 24. | A phase iv, non-inferiority, observer blind, randomized clinical study comparing safety and immunogenicity of measles-mumps-rubella (MMR) subcutaneous vaccination by disposable-syringe jet injector to vaccination by needle and syringe for the administration in healthy children in india aged 15 to 18 months |
Pharmajet USA & Serum Institute Of India Private Limited |
- |
Dr. Ashish Bavdekar |
Sep 2015-Nov 2015 |
| 25. | A phase III observer-blind, randomised, multicountry non influenza vaccine comparator controlled study to demonstrate the efficacy of GlaxoSmithkline Biologicals quadrivalent seasonal influenza candidate vaccine GSK2321138A(FLU d-QIV) administered intramuscularly in children 6-35 months of the age. |
GSK Biological |
- |
Dr. Ashish Bavdekar |
Apr 2014-Jan 2015 |
| 26. | Phase-III, multicenter, randomized, double-blind placebo-controlled study to evaluate the efficacy and safety of live attenuated bovine-human rotavirus pentavalent vaccine (BRV-PV) against severe rotavirus gastroenteritis in healthy Indian infants. |
PATH & Serum Institute Of India Private Limited |
- |
Dr. Anand Kawade |
Jun 2014-Jul 2017 |
| 27. | A phase III randomised double blind placebo controlled trial to evaluate the protective efficacy of three doses of oral rotavirus vaccine (ORV) 116E, against severe rotavirus gastroenteritis in infants. |
Department of Biotechnology (Govt. of India), Bharat Biotech, & PATH |
- |
Dr. Ashish Bavdekar |
Apr 2011-Nov 2013 |
| 28. | A phase 2a,Randomized,Controlled,Observer Blind ,Age De-Escalation,Multinational Study of Safty,Reactogenecity and Immunogenicity of the NVGH Glycoconjugate Vaccine against S.Typhi in Adults,Children,Older Infants and Infants |
Novartis India |
- |
Dr. Ashish Bavdekar |
Nov 2011-Jan 2012 |
| 29. | Pivotal study to evaluate the immunogenicity and safety of a measles vaccine given by aerosolised inhalation: randomized controlled trial |
World Health Orgnization & Serum Institute Of India Private Limited |
- |
Dr. Siddhivinayak Hirve, Dr. Ashish Bavadekar |
Sep 2009-Aug 2011 |
| 30. | A phase III double blind ranomized active controlled study to evalute the safety and consistency of immunogenicityof three consecutive lots of a menigoccoal a conjugate vaccine admin.as a single dose to healthy children 5-10yrs |
PATH & Serum Institute Of India Private Limited |
- |
Dr. Siddhivinayak Hirve, Dr. Ashish Bavadekar |
Dec 2009-Dec 2010 |
| 31. | A phase IV, open label comparative, comparative, parallel group, clinical study to evaluate the safety and immunogencity of Haemophilus influenzae Type-B vaccine (SII Hib PRO) of serum institute of India limited in indian infants |
Serum Institute Of India Private Limited |
- |
Dr. Siddhivinayak Hirve |
Jan 2008-Jan 2010 |
| 32. | A Phase II/III, observer-blind,randomized, active controlled study to compare the safety and immunogenicity of a meingococcal a conjugate vaccine (PsATT) with menigococcal ACYW polysaccharide vaccine administered in health children 2-10 years of age. |
PATH & Serum Institute Of India Private Limited |
WHO |
Dr. Siddhivinayak Hirve, Dr. Ashish Bavadekar |
Jul 2007-Dec 2008 |
Implementation Research
| Sr.No |
Title of the Project |
Funding Agency/Sponsor |
Collaborator/Association, if Any |
Principal Investigator |
Study Duration |
| 1. | Assessment of feasibility of introducing pulse oximetry in IMNCI services in primary health facilities in Pune district |
RESPIRE, University of Edinburgh |
Health Department, Zilla Parishad, Pune |
Dr. Ashish Bavdekar |
Nov 2019-Ongoing |
| 2. | Formulating and testing a strategy for introducing Pulmonary Rehabilitation (PR) for COPD management in a rural Indian setting |
RESPIRE, University of Edinburgh |
Depts. Of Pulmonolgy and Physiotherapy, KEM Hospital Pune |
Dr. Sanjay Juvekar |
Nov 2019-Ongoing |
| 3. | Implementation research on a government health program for management of high-risk pregnancies in tribal communities in Pune district: barriers, facilitators and scalability |
Alliance for Health Policy and Systems Research (HPSR) of the World Health Organization (WHO) |
Directorate of Health Services, Maharashtra State |
Dr. Sanjay Juvekar |
Aug 2019-Ongoing |
| 4. | Testing the feasibility of integrated approaches to interrupt the transmission of soil transmitted helminths(STH) - the Deworm 3 Project |
Natural History Museum UK |
Christian Medical College, Vellore |
Dr. Sanjay Juvekar |
Apr 2018-Aug 2020 |
| 5. | Enhancing LPG use during Pregnancy |
NIH- Implementation Science Network |
University of California, Berkley |
Dr. Sanjay Juvekar |
Jun 2016-Jun 2019 |
| 6. | An innovative approach to jump start simplified management of sick young infants with Possible Serious bacterial Infection (PSBI) where referral is not possible for potential scale-up |
World Health Organization |
Health Department, Zilla Parishad, Pune |
Dr. Ashish Bavdekar |
Aug 2016-Jul 2016 |
| 7. | Early Implementation of Rollout of Rotavirus Vaccine in the Public Health System Under Monitoring |
Bill and Milinda Gates Foundation |
Directorate of Health Services, Maharashtra State CHRD- Society of Applied Studies, New Delhi Christian Medical College, Vellore |
Dr. Ashish Bavdekar |
Jan 2015-Jan 2019 |
Health Technology
| Sr.No |
Title of the Project |
Funding Agency/Sponsor |
Collaborator/Association, if Any |
Principal Investigator |
Study Duration |
| 1. | Establishing a microhealth centre at Pabal village to support the primary health using teleconsultation |
Hewlett Packard and CSIR-Institute of Genomics and Integrative Biology |
CSIR-Institute of Genomics and Integrative Biology |
Dr.Sanjay Juvekar |
Apr 2015-Ongoing |
| 2. | Strengthening Immunization services in Pune district |
Science & Technology Park, Pune University |
Science & Technology Park, Pune University |
Dr. Sanjay Juvekar |
Jun 2015- Jun 2016 |
| 3. | Web GIS application for HDSS Using an Open Source Software |
INDEPTH Network |
INDEPTH |
Veena Muralidharan |
Mar 2011-Oct 2011 |
| 4. | INTREC (INDEPTH Training and Research Centres of Excellence) project |
INDEPTH |
- |
Dr. Sanjay Juvekar |
Apr 2011-Mar 2013 |
| 5. | Developing a public health informatics platform in India for a system view of health and diseases |
Department of Science and Technology |
CSIR-Institute of Genomics and Integrative Biology |
Dr. Sanjay Juvekar, Dr. C. Yajnik |
Jan 2010- Ongoing |
| 6. | INDEPTH Stats |
INDEPTH Network |
INDEPTH Network |
Dr. Sanjay Juvekar, Somnath Sambhudas |
Jun 2010- Nov 2010 |
| 7. | INDEPTH Data Sharing Project Grant No.IND/CS004a/2009 Extending & Expanding Capacity in HDSS Data Sharing among 3 African HDSS Sites in Synchronization with the Existing Data Sharing Platform among 3 Asian HDSS Sites |
INDEPTH NETWORK, Accra, Ghana (from Hewlett Foundation funds) |
Agincourt HDSS (South Africa), Dickgale (South Africa) and Magu HDSS (Tanzania) |
Dr. Sanjay Juvekar |
Feb 2009- Ongoing |
| 8. | Developing a prototype for data sharing building capacity in data management across India, Thailand and Papua New Guinea |
INDEPTH NETWORK, Accra, Ghana (from Swidish International Development Agency- SIDA funds) |
Wosera HDSS (Papua New Guinea), Kanchanaburi HDSS (Thailand) |
Dr. Sanjay Juvekar |
Jun 2005- Ongoing |
Social and Behavioral Research
| Sr.No |
Title of the Project |
Funding Agency/Sponsor |
Collaborator/Association, if Any |
Principal Investigator |
Study Duration |
| 1. | International surveillance study of movements behaviors in the early years. |
KEMHRC (Departmental Project) |
University of Wollongong, Australia |
Ms. Himangi Lubree |
Jan-2020-Ongoing |
| 2. | Social drivers of acceptance and rejection of protective measures against COVID-19 infection in the community |
KEMHRC (Departmental Project) |
- |
Dr. Sanjay Juvekar |
May 2020-July 2020 |
| 3. | Assessment of ASHA’S work load and its determinants |
Respire, University of Edinburgh |
- |
Dr. Anand Kawade |
Jan 2019-Mar 2020 |
| 4. | Prepardness of Marriage |
Indian Council for Medical Research (ICMR) |
- |
Dr. Sanjay Juvekar |
Jan 2012-Jan 2014 |
| 5. | Socio Economic status Assesment of Population for understanding health Equity in HDSS VADU Area |
INDEPTH |
INDEPTH NETWORK,Accra |
Dr. Sanjay Juvekar |
Jun 2005-Jun 2006 |
Other Intervention
| Sr.No |
Title of the Project |
Funding Agency/Sponsor |
Collaborator/Association, if Any |
Principal Investigator |
Study Duration |
| 1. | A randomised study to evaluate effect of nano-encapsulated micronutrient fortified body oils for infant massage on developmental and nutritional outcomes |
Grand Challenges Canada |
Indian Institute of Technology Bombay, Mumbai |
Dr. Ashish Bavdekar, Dr.Aditi Apte |
Dec 2017-Dec 2019 |
| 2. | Effectiveness of bovine colostrum in treatment of influenza like illness in paediatric patients |
Biostrum Nutritech Pvt. Ltd |
- |
Dr. Anand Kawade |
May 2016-Jul 2016 |
| 3. | Testing adoption of improved cookstoves in rural India after targetted behaviour intervention |
John Hopkins University Bloomberg School of Public Health, Baltimore, USA |
Chest Research Foundation, Pune |
Dr. Sandeep Salve, Dr. Ashish Bavdekar |
Apr 2013-Sep 2013 |
| 4. | Cookstove Study |
Council for Scientific and Industrial Research India and John Hopkins University |
Institute of Genomics and Integrative Biology and Chest Research Foundation, Pune |
Dr. Sanjay Juvekar |
Apr 2013-Sep2013 |
| 5. | The study of feasibility and effectiveness of conducting a community survey using mobile-phone based technology to study the prevalence of airways obstruction amongst pesticide sprayers. |
KEMHRC (Departmental Project) |
IGIB-CSIR Delhi, Govt.of India and Chest Reseach Foundation, Pune |
Dr. Sanjay Juvekar |
Sep 2013-Aug 2014 |
| 6. | Survillance for Prevention of Anemia in Children under 5- ICDS administration of low dose Sprinkles (Sprinkles II) |
Hellen Keller,Heinz |
ICDS, Government of Maharashtra |
Dr. Siddhivinayak Hirve, Dr. Sanjay Juvekar |
Apr 2009 - Mar 2010 |
| 7. | Suppliment of the Iron atta study primarily supported by the DBT , Govt. Of India |
Akzo Noble and Department of Biotechnology, Gov. of India, New Delhi and Akzo Nobel |
Department of Biotechnology |
Dr. Siddhivinayak Hirve |
Jul 2007-Sep 2008 |
| 8. | Survillance for Prevention of Anemia in Children under 5 years- administration of low dose Sprinkles (Sprinkles I) |
Hospital for Sick Kids, Toronto |
- |
Dr. Anand Pandit, Dr. Siddhivinayak Hirve, Dr. Ashish Bavdekar |
Jun 2004 -Jun 2006 |
